Stage Iii Testicular Cancer: Disease Bioinformatics
Testicular Cancer is when malignant cancer cells develop in one or both of the testicles in the germ cells. Testicular cancer is the most common cancer in men between the ages of 20-35 years old and is most commonly found in Caucasian men. Risk for developing testicular cancer are having an undescended testicle, family history, and abnormal development of the testicles. There are two main types of testicular cancers: seminomas and nonseminomas. Nonseminomas grow more rapidly and are less sensitive to radiation compared to seminomas. Testicular cancer can spread throughout the body through the tissues, the lymph system, and the blood. Stage III testicular cancer is divided into groups stage IIIA, stage IIIB, and stage IIIC. In stage IIIA, the cancer has spread to distant lymph nodes or to the lungs. Tumor marker proteins are normal or slightly elevated. At stage IIIB, the cancer has spread to more distant lymph nodes or the lungs, yet tumor markers become moderately elevated. In stage IIIC, the cancer has spread to distant lymph nodes or the lungs and tumor markers are high.
Stage Iii Testicular Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Testicular Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 375 products for the study of Stage Iii Testicular Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.